Literature DB >> 28868970

The use of nanoparticulates to treat breast cancer.

Xiaomeng Tang1,2, Welley S Loc1,2, Cheng Dong3, Gail L Matters4, Peter J Butler3, Mark Kester5, Craig Meyers6, Yixing Jiang7, James H Adair2.   

Abstract

Breast cancer is a major ongoing public health issue among women in both developing and developed countries. Significant progress has been made to improve the breast cancer treatment in the past decades. However, the current clinical approaches are invasive, of low specificity and can generate severe side effects. As a rapidly developing field, nanotechnology brings promising opportunities to human cancer diagnosis and treatment. The use of nanoparticulate-based platforms overcomes biological barriers and allows prolonged blood circulation time, simultaneous tumor targeting and enhanced accumulation of drugs in tumors. Currently available and clinically applicable innovative nanoparticulate-based systems for breast cancer nanotherapies are discussed in this review.

Entities:  

Keywords:  breast cancer; gene/drug delivery; nanoparticles

Mesh:

Year:  2017        PMID: 28868970      PMCID: PMC5612024          DOI: 10.2217/nnm-2017-0202

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  135 in total

1.  Nanogeometry: beyond drug delivery.

Authors:  Mauro Ferrari
Journal:  Nat Nanotechnol       Date:  2008-03       Impact factor: 39.213

2.  Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation.

Authors:  A L Silva; R A Rosalia; A Sazak; M G Carstens; F Ossendorp; J Oostendorp; W Jiskoot
Journal:  Eur J Pharm Biopharm       Date:  2012-11-29       Impact factor: 5.571

Review 3.  Temperature-sensitive polymers for drug delivery.

Authors:  Scott D Fitzpatrick; Lindsay E Fitzpatrick; Ajit Thakur; Mohammad A Jafar Mazumder; Heather Sheardown
Journal:  Expert Rev Med Devices       Date:  2012-07       Impact factor: 3.166

4.  Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

Authors:  Nuhad K Ibrahim; Neil Desai; Sewa Legha; Patrick Soon-Shiong; Richard L Theriault; Edgardo Rivera; Bita Esmaeli; Sigrid E Ring; Agop Bedikian; Gabriel N Hortobagyi; Julie A Ellerhorst
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

5.  Gold nanoshell bioconjugates for molecular imaging in living cells.

Authors:  Christopher Loo; Leon Hirsch; Min-Ho Lee; Emmanuel Chang; Jennifer West; Naomi Halas; Rebekah Drezek
Journal:  Opt Lett       Date:  2005-05-01       Impact factor: 3.776

6.  p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.

Authors:  R M Hudziak; G D Lewis; M Winget; B M Fendly; H M Shepard; A Ullrich
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

Review 7.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

Authors:  Michelle Longmire; Peter L Choyke; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2008-10       Impact factor: 5.307

Review 8.  Protein nanoparticles as drug carriers in clinical medicine.

Authors:  Michael J Hawkins; Patrick Soon-Shiong; Neil Desai
Journal:  Adv Drug Deliv Rev       Date:  2008-02-07       Impact factor: 15.470

9.  Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer.

Authors:  M E R O'Brien; N Wigler; M Inbar; R Rosso; E Grischke; A Santoro; R Catane; D G Kieback; P Tomczak; S P Ackland; F Orlandi; L Mellars; L Alland; C Tendler
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

Review 10.  Drug insight: Use of docetaxel in prostate and urothelial cancers.

Authors:  Niklas J Mackler; Kenneth J Pienta
Journal:  Nat Clin Pract Urol       Date:  2005-02
View more
  12 in total

1.  Effect of Zinc Supplementation on the Serum Metabolites Profile at the Early Stage of Breast Cancer in Rats.

Authors:  Barbara Bobrowska-Korczak; Paulina Gątarek; Dorota Skrajnowska; Wojciech Bielecki; Rafal Wyrebiak; Tomas Kovalczuk; Robert Wrzesień; Joanna Kałużna-Czaplińska
Journal:  Nutrients       Date:  2020-11-11       Impact factor: 5.717

Review 2.  Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment.

Authors:  Alberto Juan; Francisco J Cimas; Iván Bravo; Atanasio Pandiella; Alberto Ocaña; Carlos Alonso-Moreno
Journal:  Int J Mol Sci       Date:  2020-08-21       Impact factor: 5.923

3.  A Perspective on Cell Tracking with Magnetic Particle Imaging.

Authors:  Olivia C Sehl; Julia J Gevaert; Kierstin P Melo; Natasha N Knier; Paula J Foster
Journal:  Tomography       Date:  2020-12

4.  The Influence of Supplementation with Zinc in Micro and Nano Forms on the Metabolism of Fatty Acids in Livers of Rats with Breast Cancer.

Authors:  Agnieszka Stawarska; Małgorzata Czerwonka; Małgorzata Jelińska; Iga Piasecka; Barbara Bobrowska-Korczak
Journal:  Nutrients       Date:  2021-10-27       Impact factor: 5.717

5.  Modulatory Effects of Biosynthesized Gold Nanoparticles Conjugated with Curcumin and Paclitaxel on Tumorigenesis and Metastatic Pathways-In Vitro and In Vivo Studies.

Authors:  Satish Kumar Vemuri; Satyajit Halder; Rajkiran Reddy Banala; Hari Krishnreddy Rachamalla; Vijaya Madhuri Devraj; Chandra Shekar Mallarpu; Uttam Kumar Neerudu; Ravikiran Bodlapati; Sudip Mukherjee; Subbaiah Goli Peda Venkata; Gurava Reddy Annapareddy Venkata; Malarvilli Thakkumalai; Kuladip Jana
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

6.  Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis.

Authors:  Yara E Elakkad; Shimaa Nabil Senousy Mohamed; Nermeen Z Abuelezz
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-12-14

7.  Mechanisms of Drug Resistance and Use of Nanoparticle Delivery to Overcome Resistance in Breast Cancers.

Authors:  Huseyin Beyaz; Hasan Uludag; Doga Kavaz; Nahit Rizaner
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer.

Authors:  Simona Camorani; Ilaria Granata; Francesca Collina; Francesco Leonetti; Monica Cantile; Gerardo Botti; Monica Fedele; Mario Rosario Guarracino; Laura Cerchia
Journal:  iScience       Date:  2020-03-12

9.  Zinc Affects Cholesterol Oxidation Products and Fatty Acids Composition in Rats' Serum.

Authors:  Agnieszka Stawarska; Małgorzata Czerwonka; Rafał Wyrębiak; Robert Wrzesień; Barbara Bobrowska-Korczak
Journal:  Nutrients       Date:  2021-05-06       Impact factor: 5.717

Review 10.  Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and Challenges.

Authors:  Md Rizwanullah; Mohammad Zaki Ahmad; Mohammed M Ghoneim; Sultan Alshehri; Syed Sarim Imam; Shadab Md; Nabil A Alhakamy; Keerti Jain; Javed Ahmad
Journal:  Pharmaceutics       Date:  2021-11-29       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.